Baillie Gifford & CO Bio N Tech Se Put Options Transaction History
Baillie Gifford & CO
- $128 Billion
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding BNTX
# of Institutions
341Shares Held
40.4MCall Options Held
1.55MPut Options Held
1.46M-
Flossbach Von Storch Ag Cologne, 2M4.26MShares$474 Million1.71% of portfolio
-
Primecap Management CO Pasadena, CA4.05MShares$450 Million0.31% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$211 Million0.0% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U01.81MShares$201 Million0.84% of portfolio
-
Capital International Investors Los Angeles, CA1.43MShares$159 Million0.03% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $27B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...